Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SYRE | ALKS | RYTM | ||
| Company | Spyre Therapeutics Inc | Alkermes Plc | Rhythm Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 91.75 | 48.82 | 110.21 | ||
| High | 93.39 | 48.82 | 114.75 | ||
| Low | 89.45 | 47.25 | 107.09 | ||
| Last | 90.36 | 47.41 | 107.17 | ||
| Change | -3.25 | -1.49 | -5.36 | ||
| Percent Change | -3.48% | -3.05% | -4.76% | ||
| Volume | 1,266,500 | 1,429,200 | 441,200 | ||
| 20-Day Average Volume | 966,560 | 1,357,755 | 646,625 | ||
| Previous | 93.61 | 48.90 | 112.53 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 102.87 | 49.16 | 112.31 | ||
| 20-Day Raw Stochastic | 4.39% | 3.63% | 43.30% | ||
| 20-Day Relative Strength | 42.04 | 44.18 | 47.84 | ||
| Weighted Alpha | +302.31 | +65.13 | +7.80 | ||
| Today's Opinion | 56% Buy | 40% Buy | 48% Buy | ||
| Yesterday's Opinion | 56% Buy | 40% Buy | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 80% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -15.15% since 08/21/26 | -1.90% since 08/21/26 | -2.57% since 08/21/26 | ||
| Low | 89.45 on 08/28/26 | 47.25 on 08/28/26 | 107.09 on 08/28/26 | ||
| High | 110.15 on 08/25/26 | 49.58 on 08/25/26 | 114.75 on 08/28/26 | ||
| 1-Month | |||||
| %Chg | -9.60% since 07/28/26 | -6.12% since 07/28/26 | -0.81% since 07/28/26 | ||
| Low | 89.45 on 08/28/26 | 47.25 on 08/28/26 | 97.57 on 08/04/26 | ||
| High | 110.18 on 08/19/26 | 51.66 on 08/13/26 | 119.75 on 08/13/26 | ||
| 3-Month | |||||
| %Chg | +25.31% since 05/28/26 | +18.70% since 05/28/26 | +15.26% since 05/28/26 | ||
| Low | 68.50 on 06/02/26 | 39.64 on 05/29/26 | 82.89 on 06/02/26 | ||
| High | 110.18 on 08/19/26 | 55.67 on 07/07/26 | 119.75 on 08/13/26 | ||
| 6-Month | |||||
| %Chg | +110.09% since 02/27/26 | +57.51% since 02/27/26 | +15.57% since 02/27/26 | ||
| Low | 38.36 on 03/06/26 | 27.00 on 03/19/26 | 74.50 on 03/30/26 | ||
| High | 110.18 on 08/19/26 | 55.67 on 07/07/26 | 119.75 on 08/13/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,945,896 | 7,953,644 | 7,344,681 | ||
| Shares Outstanding, K | 87,936 | 167,763 | 68,533 | ||
| Annual Sales, $M | 0 | 1,475,900,000 | 189,760,000 | ||
| Annual Net Income, $M | -155,200,000 | 241,660,000 | -196,540,000 | ||
| Last Qtr Sales, $M | 0 | 496,010,000 | 71,260,000 | ||
| Last Qtr Income, $M | -36,200,000 | 500,000 | -49,300,000 | ||
| 60-Month Beta | 3.03 | 0.34 | 1.92 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.36 on 08/04/26 | 0.00 on 07/28/26 | -0.73 on 08/04/26 | ||
| Latest Earnings Date | 11/03/26 | 10/27/26 | 11/03/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 113.72 | 0.00 | ||